Rutishauser W J
Cardiology Center, University Hospital, Geneva, Switzerland.
Cardiovasc Drugs Ther. 1989 Dec;3(6):931-3. doi: 10.1007/BF01869584.
Extrapolation from one country to another concerning costs of treatment of essential hypertension has to be made with caution because of wide variation of socio-economic differences and governmental price setting attitudes. The worldwide antihypertensive drug market shows a strong increase in the last few years and reflects the evolution away from diuretics and toward the more expensive ACE inhibitors and calcium antagonists, with a decreasing percent market of beta-blockers and absolute stagnation in other antihypertensives outside these four groups of drugs.
由于社会经济差异和政府定价态度存在很大差异，因此在不同国家之间推断原发性高血压的治疗成本时必须谨慎。在过去几年中，全球抗高血压药物市场呈现出强劲增长态势，反映出用药模式已从利尿剂转向更昂贵的血管紧张素转换酶（ACE）抑制剂和钙拮抗剂，β受体阻滞剂的市场份额在下降，而在这四类药物之外的其他抗高血压药物市场则完全停滞不前。
